On October 26, 2017 Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology Company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, reported that it will host a teleconference and webcast with management to discuss the third quarter 2017 financial results, provide an update on the Company’s business, and discuss expectations for the future (Press release, Spectrum Pharmaceuticals, OCT 26, 2017, View Source [SID1234521203]).

Conference Call

Thursday, November 2, 2017 @ 4:30 p.m. Eastern/1:30 p.m. Pacific

Domestic: (877) 837-3910, Conference ID# 7488227
International: (973) 796-5077, Conference ID# 7488227

For interested individuals unable to join the call, a replay will be available from November 2, 2017 @ 7:30 p.m. ET/4:30 p.m. PT through November 12, 2017 until 11:59 p.m. ET/8:59 p.m. PT.

Domestic Replay Dial-In #: (855) 859-2056, Conference ID# 7488227
International Replay Dial-In #: (404) 537-3406, Conference ID# 7488227

This conference call will also be webcast. Listeners may access the webcast, which will be available on the investor relations page of Spectrum Pharmaceuticals’ website: www.sppirx.com on November 2, 2017 at 4:30 p.m. Eastern/1:30 p.m. Pacific.

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) will publish its first nine months’ 2017 results on November 7, 2017 at 7:00 am CET (Press release, MorphoSys, OCT 26, 2017, View Source [SID1234521200]).

At 2:00 pm CET (1:00 pm GMT, 8:00 am EST), the Management Board of MorphoSys AG will host a public conference call and webcast to present MorphoSys’s financial results for the first nine month of 2017 and provide further details on the Company’s latest developments.

Dial-in numbers (listen only):

Germany: +49 89 2444 32975

United Kingdom: +44 20 3003 2666

USA: +1 202 204 1514

We request that you please dial in up to 10 minutes before the call to ensure a prompt start and a secure line.

The presentation slides and webcast link will be available at the Company’s website at www.morphosys.com/conference-calls

A slide-synchronized audio replay of the conference will also be available at the corporate website following the live event.

On October 26, 2017 Inovio Pharmaceuticals, Inc. (NASDAQ:INO) reported that it will host a conference call and live webcast to report its 2017 third quarter financial results on Wednesday, November 8, 2017 at 4:30 p.m. ET (Press release, Inovio, OCT 26, 2017, View Source [SID1234521198]).

A live and archived version of the audio presentation will be available online at View Source as well as through the “Webcast” tab on Inovio’s home page at www.inovio.com. This is a listen-only event but will include a live Q&A with analysts.

A replay of the conference call will be accessible two hours after the call at 877-481-4010 (domestic) or 919-882-2331 (international) using replay ID 20915.

On October 26, 2017 Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, reported that it will host a conference call and live audio webcast on Thursday, November 2, 2017 at 9:00 a.m. ET to discuss financial results for the third quarter of 2017 (Press release, Genocea Biosciences, OCT 26, 2017, View Source [SID1234521197]). Genocea management will also provide an update on the Company’s recent progress and upcoming milestones.

Interested participants may access the conference call by dialing (844) 826-0619 (domestic) or (315) 625-6883 (international) and refer to conference ID number 95267931. To join the live webcast, please visit the investor relations section of the Genocea website at View Source

A webcast replay will be available on the Genocea website beginning approximately two hours after the event, and will be archived for 30 days.